January 13, 2025 - 03:32
In a recent conversation, Dream Theater's keyboardist Jordan Rudess shared his insights on the role of artificial intelligence (A.I.) in the music industry. Addressing concerns about A.I. potentially disrupting traditional music creation, Rudess expressed a more optimistic view. He emphasized that he does not believe A.I. will lead to catastrophic outcomes, likening it to previous technological advancements that have transformed the music landscape.
Rudess acknowledged the growing presence of A.I. in music but highlighted that it should be seen as a tool rather than a replacement for human creativity. He believes that, like any technology, A.I. can enhance the creative process when used thoughtfully. The musician pointed out that artists have always adapted to new tools, and A.I. is simply the latest in a long line of innovations that can inspire new forms of expression.
Ultimately, Rudess remains hopeful about the future of music, seeing A.I. as an opportunity for collaboration rather than a threat. His perspective encourages musicians to embrace these advancements while maintaining their unique artistic voices.
July 1, 2025 - 12:35
Westville Library Receives Grant for Technology and Internet EnhancementsWESTVILLE — In an era where technology is rapidly transforming our daily lives, the Westville Public Library in Vermilion County is taking significant steps to modernize its services. The library...
June 30, 2025 - 22:18
Webstar Technology Group Secures Contract for "The Forge" Project in Downtown AtlantaWebstar Technology Group, a prominent player in real estate development and digital asset innovation, has officially placed its transformative project, `The Forge,` under contract in the heart of...
June 30, 2025 - 04:30
Voice-Based Risk Assessment Firm Secures $60 Million in Series D FundingClearspeed, a prominent player in the voice-based risk assessment technology sector, has successfully raised $60 million in its Series D funding round. This latest investment elevates the company`s...
June 29, 2025 - 04:10
First Patient Enrolled in Groundbreaking Study on MicroPulse Technology for DMEA significant milestone has been reached in a clinical study evaluating the effectiveness of MicroPulse technology as an adjunct to anti-VEGF therapy for patients suffering from diabetic macular...